CARF and hepatocellular carcinoma: In addition, ICG001, the inhibitor for beta-catenin/TCF complex, abolished the promoting effects of CARF on the growth and migration of 7404 cells (Figure 5D), suggesting that CARF promoted the progression of HCC by positively regulating beta-catenin/TCF signaling.